Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 30S ribosomal subunit 16S rRNA decoding site, commonly known as the A-site, is a highly conserved and essential functional region within the bacterial ribosome. It plays a pivotal role in protein synthesis by ensuring the fidelity of translation through the accurate selection of aminoacyl-tRNAs based on mRNA codons (Vicens & Westhof, 2001 [PMID: 11557972]). Key nucleotides within this site, such as A1492, A1493, and G530, undergo critical conformational changes to validate codon-anticodon base pairing. This site is the primary target for aminoglycoside antibiotics, which bind to the internal loop of helix 44 in the 16S rRNA, causing the ribosome to misread the genetic code and produce defective proteins (Kohanski et al., 2010 [PMID: 20360735]). Additionally, tetracyclines target this region to prevent tRNA binding, effectively halting translation. While these drugs are potent antibacterials, their clinical use is often limited by significant safety concerns, including permanent ototoxicity and reversible nephrotoxicity, largely due to structural similarities between bacterial and human mitochondrial ribosomes (Mingeot-Leclercq & Tulkens, 1999 [PMID: 10223914]). Resistance to drugs targeting this site is frequently mediated by 16S rRNA methyltransferases that modify the binding pocket (Doi et al., 2016 [PMID: 27324764]). Understanding the structural dynamics of this site remains crucial for the development of next-generation antibiotics with improved safety profiles.
Aminoglycosides bind to the 16S rRNA A-site, inducing a conformational change in nucleotides A1492 and A1493 that mimics the state of correct codon-anticodon pairing, leading to mistranslation and cell death (Vicens & Westhof, 2001 [PMID: 11557972]). Tetracyclines bind to the same region to sterically block the entry of aminoacyl-tRNA, thereby inhibiting protein synthesis (Magnet & Blanchard, 2005 [PMID: 15807530]).
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 30S ribosomal subunit 16S rRNA decoding site (16S rRNA A-site).